Table: Towa Pharmaceutical - 9-MTH group results

TOWA PHARMACEUTICAL

12/02/2019 06:00

Feb 12 (Reuters)- 
             Towa Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               78.29               70.41           104.00    
                   (+11.2 pct)         (+10.5 pct)      (+11.3 pct) 
  Operating           11.96                9.21            15.00    
                   (+29.8 pct)         (+67.2 pct)      (+28.8 pct) 
  Recurring           14.56               10.47            16.30    
                   (+39.1 pct)         (+61.2 pct)      (+39.1 pct) 
  Net                 10.46                7.37            11.50    
                   (+41.8 pct)         (+53.5 pct)      (+77.0 pct) 
  EPS              637.39 yen          449.52 yen       701.09 yen  
  EPS Diluted      589.62 yen          415.74 yen                   
  Ann Div                               95.00 yen       107.50 yen  
  -Q2 div           47.50 yen           47.50 yen                   
  -Q4 div                               47.50 yen        60.00 yen  
  
  NOTE - Towa Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4553.T